Tomoko Hasunuma, MD., PhD., Professor, Department of Kitasato Clinical Research Center, (KCRC) Kitasato University School of Medicine, and also Director, Clinical Trial Center, Department of Research, Kitasato University Kitasato Institute Hospital, is recognized as one of well-known clinical pharmacologist in Japan. She has been experienced numbers of early-phase and later-phase clinical trials as a primary investigator.
She graduated from medical course of Tokyo Women’s Medical University (TWMU) in 1987, and started her internal medicine residency at the same university hospital. After she finished her residency, she started her basic and clinical research on Rheumatology at Rheumatology center of TWMU, then became a research fellow at New England Regional Primate Research Center (now closed) of Harvard University in 1989. Since 1990, she started working as a research associate at Institute of Medical Science, St. Marianna University, Japan, and several reports on etiology and therapy of rheumatoid arthritis. She moved to Kitasato Institute in 1999, and started her clinical research carrier. She accomplished substantial number of clinical trials as a primary investigator until 2012, when she moved as an assistant professor to clinical division of rheumatology at Toho University school of Medicine, Tokyo. In 2015, she was welcomed to Oita University school of medicine as an associate professor of clinical pharmacology, where she accomplished several clinical studies and also educations for medical and nursery students.
Since 2017, she returned to Kitasato University as a professor of medicine, and now she is continuing clinical studies and investigations. She is also a councilor of Japanese Society of Clinical Pharmacology and Therapeutics, and doing commission works.
Journal of Clinical Investigation and Studies accepts direct submissions from authors: Attach your word file with e-mail and send it to:firstname.lastname@example.org alternatively to: email@example.com
Journal of Journal of Clinical Investigation and Studies is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.
The publication charges for Journal of Clinical Investigation and Studies are USD 400.
Frequently Asked Questions (FAQs)
Why are your charges set at these levels?
All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.
Our financial goals are to:
- Recover capitalization costs;
- Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
- Bend the publication-charge cost downward over time.
Who will pay the APC?
Corresponding author or Co-authors has to make the payment on acceptance of the article.
When should I pay?
Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.
*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.
How do I pay?
Authors or institutions can make payments by two modes as per their convenience.
- Wire/Bank transfer
- Card payment
Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.
Can I be eligible for wavier on APC?
The waiver request will be considered on a case-by-case basis, and will be provided accordingly.
*The Waiver requests must be made during the submission process and will not be accepted after processing of the manuscript.
Do I have to pay if my manuscript is rejected?
No, Article processing charges will not be applicable for articles rejected by the Editorial office.
Are reprints of my article included in the article processing charges (APCs)?
No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.